44 2033180199

Malignant pleural effusion survival controlled by lent and promise scores.

Amy Raw

One disease, known as Malignant Pleural Effusion (MPE), is present in 15% of cancer patients. Finding the right treatment is crucial given the short overall survival rate. It should be determined whether cases require a more vigorous course of treatment in addition to palliating secondary symptoms brought on by MPE. The aim of the study was to assess how well LENT and clinical PROMISE scores predicted survival in MPE patients.

అసోకేషన్స్, సొసైటీలు మరియు యూనివర్శిటీల కోసం పీర్ రివ్యూ పబ్లిషింగ్ pulsus-health-tech